Skip to content

Does virtual reality in the preoperative setting for colorectal cancer surgery improve patient understanding? A randomised pilot study.

Does virtual reality in the preoperative setting for colorectal cancer surgery improve patient understanding? A randomised pilot study.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12622000347763
Acronym
VR CRC
Enrollment
9
Registered
2022-02-25
Start date
2021-11-01
Completion date
2022-01-23
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purpose of this study is to assess whether virtual reality (VR) is a feasible technique for improving patient understanding for the purposes of consent for surgery in individuals with colorectal cancer. Who is it for? You may be eligible for this study if you are aged 18 years or older and are planned for elective surgical resection of colorectal cancer. Study details After their standard consultation with the colorectal surgeon, participants will be randomised (i.e. allocated by chance) to undergo either standard consent process or VR consent. All participants will be shown their 2D CT images with the researcher as a part of standard consent, which will take approximately 20 minutes. These images are in greyscale and permit viewing of only one ‘slice’ of the body at one time. Following this, participants in the VR consent group will additionally be shown immersive VR three dimensional models of the anatomy and pathology relevant to the proposed surgery, which will take an additional 20 minutes. Immediately after completion, participants will answer a questionnaire to determine their understanding of the proposed operation and satisfaction with the consent process. Data will also be collected to determine the feasibility and cost of delivering VR consent to patients. It is hoped that this study may show that VR is feasible, effective, and acceptable to patients for obtaining consent prior to surgery for colorectal cancer.

Interventions

All patients discussed the diagnosis and planned procedure with their colorectal surgeon to sign a standard consent form and discuss trial participation. For all patients, this was the first consultation to discuss surgery for their bowel cancer. During this encounter, the surgeon could use drawings and information sheets to aid discussion but not the patient’s computed tomography (CT) images. Patients were then taken to a separate office by the researcher during the same clinic appointment. In

All patients discussed the diagnosis and planned procedure with their colorectal surgeon to sign a standard consent form and discuss trial participation. For all patients, this was the first consultation to discuss surgery for their bowel cancer. During this encounter, the surgeon could use drawings and information sheets to aid discussion but not the patient’s computed tomography (CT) images. Patients were then taken to a separate office by the researcher during the same clinic appointment. In the intervention group, case discussion was done with both 2D CT images and virtual reality (VR) images to allow for comparison. Patients in the intervention group received a brief 2-5 minute orientation regarding the headsets and controllers before being shown 2 different VR models while seated. The first model was a representative model of the large bowel with superimposed bony and skin anatomy created from a de-identified patient CT colonography. This virtual environment allowed patients to orient themselves to key surface and bony anatomy while also learning to use the controllers on instruction from the researcher. The second model was an individualised VR reconstruction created from patient’s own preoperative staging CT scans. Patients had unlimited use of the controllers to scroll through and view the model from all angles in the virtual environment, where key anatomy was pointed out by the researcher who was not in the virtual environment but giving verbal instructions while monitoring the VR environment on a computer screen. On average the intervention group spent 40 minutes with the researcher. To standardise the information given to both trial groups, a checklist of key discussion points was followed including key relational anatomy, tumour location and procedure/complication specific anatomy. Headsets and controllers were wiped down with Tuffie 5 universal sanitising wipes between patients. Image generation To create the VR models, Deidentified Digital Imaging and Communications in Medicine (DICOM) data for each CT were imported into D2P software (3D Systems Inc, Melbourne Aus.) and relevant anatomy segmented using standard software modules and a dedicated Acer Nitro 5 laptop. D2P employs a technique known as image segmentation, which identifies each relevant anatomical structure separately and enables them to be independently rendered. Each individual structure is assigned a unique colour (thereby enhancing visual differentiation), and may also be hidden from view to focus on the most critical structures and relationships. Segmentation of the large bowel on the representative VR model took 12 hours to complete due to the high level of detail achieved.

Sponsors

St John of God Hospital
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Inclusion criteria will be participants age 18 years and over who are planned for elective colorectal cancer resection.

Exclusion criteria

Patients will be excluded from the study based on history of vestibulocochlear abnormalities, diagnosis of epilepsy, stroke within the last 3 months, head or neck injury preventing safe use of the VR headsets or diagnosed cognitive impairment

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026